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Table 1. Demographic characteristics of patients according to the localization
of infarction
Anterior MI (n:24) Inferior MI (n:24) p-value
Age 52, 813, 2 (27-74) 55, 613, 1 (28-78) 0, 460
Gender 1, 000
Male 21 (%87, 5) 20 (%83, 3)
Female 3 (%12, 5) 4 (%16, 7)
HT 5 (%20, 8) 5 (%20, 8) 1, 000
DM 7 (%29, 2) 5 (%20, 8) 0, 505
Smoking 16 (%66, 7) 13 (%54, 2) 0, 376
(HT: Hypertension, DM: Diabetes mellitus)
Table 2. Turbulence onset and turbulence slope values in groups
Anterior MI (n:24) Inferior MI (n:24) p-value
TO -1, 9 (-16, 0 – 6, 8) -1, 7 (-10, 0 – 2, 3) 0, 483
TS 12, 6 (4, 6-90, 8) 9, 4 (3, 2-86, 0) 0, 733
(TO: Turbulence onset, TS: Turbulence slope)
Table 3. Turbulence onset and slope levels due to history of HT and DM
TO TS
HT
(+) -1, 7 (-11, 8 – 1, 6) 9, 4 (4, 6-70, 2)
(-) -1, 8 (-16, 0 – 6, 8) 13, 3 (3, 2-90, 8)
p value 0, 774 0, 415
DM
(+) -0, 6 (-11, 8 – 1, 9) 7, 0 (4, 6-17, 2)
(-) -2, 0 (-16, 0 – 6, 8) 14, 0 (3, 2-90, 8)
p value 0, 273 0, 023
HT: Hypertension, DM: Diabetes Mellitus, TO: Turbulence onset, TS: Turbulence slope
Table 1. Demographic, clinical and echocardiographic characteristics of the
study population
Group 1 Group 2 Group 3 p value
Age (mean  SD), years 70.48.6 70.09.7 68.99.1 0.446
Gender Male,(%) Female,(%) 52 (41.6)
73 (58.4)
45 (36.0)
80 (64.0)
49 (39.8)
74 (60.2)
0.650
Hypertension, (%) 88 (70.4) 79 (63.2) 83 (67.5) 0.476
Diabetes mellitus, (%) 6 (4.8) 8 (6.4) 9 (7.3) 0.706
Hyperlipidemia, (%) 48 (38.4) 61 (48.8) 57 (46.3) 0.323
Smoking, (%) 16 (12.8) 12 (9.6) 18 (14.6) 0.413
Beta blocker, (%) 68 (54.4) 72 (57.6) 80 (65.0) 0.218
ACEi or ARB, (%) 79 (63.2) 70 (56.0) 68 (55.3) 0.375
CCB, (%) 43 (34.4) 40 (32.0) 32 (26.0) 0.339
Diuretic, (%) 40 (32.0) 33 (26.4) 27 (22.0) 0.201
CHA2DS2-VASc score
(meanSD)
2.771.1 2.791.1 N/A 0.8721
LVEF, % 56.12.7 54.23.1 57.42.8 0.564
Left atrium, mm 44.63.5 45.23.8 35.22.8 <0.0012*
ACEi ¼ Angiotensin-converting enzyme inhibitor, ARB¼ Angiotensin II receptor blocker, CCB¼
calcium channel blocker, LVEF¼ left ventricule ejection fraction, SD¼ standart deviation
*difference lies between Group 3 and Group 1/2
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Background: Atrial ﬁbrillation (AF) is the most common sustained arrhythmia and
associated with adverse outcomes and increased risk for thromboembolic events.
Warfarin is still the most extensively prescribed oral anticoagulant in AF to prevent
ischemic complications. It has been shown that larger platelets are more active and
protrombotic than smaller ones.. Platelet indices including mean platelet volume
(MPV), platelet distribution width (PDW), plateletcrit (PCT) are routinely measured inC142 JACC Vocomplete blood cell counts (CBCs) without additional costs and investigated in many
conditions. We aimed to determine the differences at platelet indices with warfarin
usage layered by International Normalized Ratio (INR).
Methods: 250 patients with permanent non-valvular AF (mean age 70.2  9.1; 153
female) were divided into 2 groups. Group 1 included 125 patients whose INR is
between 2.0 and 3.0 (called as “effective”) and Group 2 included 125 patients whose
INR is <2.0 (called as “inefective”). Also 123 age- and sex-matched healthy indi-
viduals enrolled as control group (Group 3). After physical and echocardiographic
examination, complete blood counts and INR were studied.
Results: There was no statistically signiﬁcant difference in age, sex, comorbidities and
medications, also hemoglobin, white blood cell and platelet counts among the groups.
The CHA2DS2-VASc scores were similar between Group 1 and Group 2. Mean
MPV, median PCT and PDW were signiﬁcantly higher in Group 2 than Group 1 and
Group 3 and similar between Group 1 and 3. MPV was correlated with PDW
(r¼0.454, p<0.001) and PCT (r¼0.208, p¼0.001) also inversely correlated with INR
(r¼-0.455, p<0.001) and platelet count (r¼-0.307, p<0.001). In ROC curve analysis
the area under curve values (AUC) were 0.778 (cut-off value 7.76; p<0.001) for
MPV, 0.662 (cut-off value 17.7; p<0.001) for PDW and 0.657 (cut-off value 0.192;
p<0.001) for PCT. In multivariate logistic regression analysis by using these cut-off
values MPV, PDW and PCT were found to be independent predictors of risk of INR
ineffectiveness (OR: 5.194; p<0.001; 95% CI 2.829-9.535 for MPV, OR: 2.137;
p¼0.013; 95% CI 1.171-3.898 for PDW and OR: 2.854; p<0.001; 95% CI 1.586-
5.135 for PCT).
Conclusıon: The results of this study showed that MPV, PDW and PCT are increased
in patients with non-valvular AF without effective warfarin treatment. Warfarin usage
adjusted by INR is associated with lower values of these platelet indices, even lower
as the values of healthy subjects. MPV, PDW and PCT are independent predictors of
INR ineffectiveness and seem to be useful parameters for monitoring the effectiveness
of warfarin treatment.l 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
Table 2. The laboratory ﬁndings of the study population
Group 1 Group 2 Group 3
p
Overall
p
Group
1-3
p
Group
2-3
p
Group
1-2
INR, % 2.54
(2.01-
2.99)
1.37
(0.94-
1.95)
0.97
(0.85-
1.21)
<0.001 <0.001 <0.001 <0.001
Hemoglobin,
g/dL
12.0
(11.0-
16.8)
12.0
(11.4-
16.3)
13.0
(11.7-
16.2)
0.193 - - -
WBC,
x1000/mL
7.34
(3.92-
11.3)
7.43
(3.91-
11.2)
7.12
(4.31-
11.0)
0.295 - - -
Platelet,
x1000/mL
236
(119-442)
219
(135-382)
236
(151-400)
0.173 - - -
MPV, fL 7.56
0.63
8.26
0.63
7.63
0.68
<0.001 0.710 <0.001 <0.001
PCT, % 0.174
(0.089-
0.274)
0.203
(0.106-
0.311)
0.183
(0.099-
0.304)
<0.001 0.433 <0.001 <0.001
PDW, % 17.3
(14.2-
19.4)
17.9
(13.7-
20.5)
17.5
(15.4-
19.7)
<0.001 0.165 0.004 <0.001
INR¼ International normalized ratio, MPV¼ Mean platelet volume, PCT¼ Plateletcrit, PDW¼
Platelet distribution width, WBC¼ White blood cell
Human platelet antigens -1 gene polymorphisms genotype and allel frequencies
AF patients
with stroke
(n:70)
Control
(n:65) P
n: % n: %
1a1a
genotype
49 70 57 87.7 0.012
1a1b
genotype
18 25.7 6 9.2 0.012
1b1b
genotype
3 4.3 1 1.5 0.347
1a1b + 1b1b
genotypes
(Dominant
genetic
model)
21 30 7 10.8 0.006
1b allel 24 17.1 8 6.1 0.009
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Background: Atrial ﬁbrillation (AF) is the commonest sustained cardiac arrhythmia,
which confers a high risk of mortality and morbidity from stroke and thromboem-
bolism. Altered platelet activation and platelet-dependent thromboembolism have
been associated with the pathogenesis of cardiovascular or thromboembolic disorders,
which include atherosclerosis, coronary disease and cerebrovascular disease. Platelet
adhesion and activation are mediated by human platelet alloantigens (HPAs),
a complex of platelet membrane glycoproteins (Gp) and other cellbound Factors. By
altering platelet receptor sensitivity, polymorphisms in platelet Gp directly impact
platelet susceptibility to activating stimuli, which is linked with an increased risk of
atherothrombotic events, including acute myocardial infarction. We wanted to
investigate HPA-1 polymorphism in patients with AF who have had a stroke than in
healthy controls.
Methods: The HPA-1 polymorphism was analysed in 70 patients with nonvalvuler
AF who have had a stroke and 65 healthy individuals with no documented episode of
AF matched for age, race and sex. Because ethnic differences have been reported
for HPA-1. The HPA-1 gene polymorphism was identiﬁed by polymerase chain
reaction (PCR) method. Distribution of the HPA-1 gene polymorphism alles (allel 1a,
allel 1b) genotypes (1a1a, 1a1b and 1b1b) were determined in study population.
Demographic characteristics and risk factors for AF and stroke were evaluated in the
study groups.
Results: There was no signiﬁcant difference with respect to age and gender between
groups. Genotype and allel distribution of AF patients who have had a stroke
and control groups shown in the table. The frequency of 1a1a genotype of HPA-1
polymorphism was signiﬁcantly lower in patients with AF patients who have had
a stroke group compared with control group (49 (70%) vs 57 (87.7%), p¼0.012). The
frequency of 1a1b genotype heterozygous genotype was signiﬁcantly higher in
AF patients who have had a stroke group than control (18 (25.7%) vs 6 (9.2%),
p¼0.012). Between the two groups were compared according to the dominant
genetic model (1a1b + 1b1b vs. 1a1a), The number of patients carrying at least one 1b
mutant allele (1a1b + 1b1b) was signiﬁcantly higher in AF patients who have
had a stroke group than control (21 (30%) vs 7 (10.8%), p¼0.006). With respect to
allelic distribution (1a vs 1b, additive model), the frequency of the 1b allele was
signiﬁcantly higher in AF patients who have had a stroke (24 (17.1%) vs 8 (6.1%),
p¼0.009).
Conclusıons: In this study, our data suggest that the HPA-1 gene polymorphisms may
be associated with AF patients who have had a stroke from other clinical risk factors,
but this should be conﬁrmed in a much larger series of patients. Screening for this
mutation may help in identifying patients at risk and in deciding the antithrombotic
strategy.JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTPP-158
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Objectıve: Prediabetes is a predictor of manifest diabetes mellitus (DM) and is known
to be associated with increased cardiovascular mortality and morbidity. As the diabetic
patients are at higher risk of developing atrial ﬁbrillation (AF), a signiﬁcant part of the
patients with lone AF are also diabetic. Inter-atrial and intra-atrial electromechanical
coupling time which can be measured by both prolonged P wave dispersion and tissue
Doppler imaging are known as the non-invasive predictors of atrial ﬁbrillation.
Impairment of left mechanical functions could be associated with the increased risk of
developing AF. In our study, we examined the atrial electromechanical coupling time
which is measured by the tissue Doppler imaging (TDI), left atrial (LA) mechanical
function by disc method, and P wave dispersion of the prediabetic patients.
Matherıal-Method: 50 prediabetic (22 M, 28 F; median age: 5110 years) and 41
healthy subjects as control group included in this study. Atrial electromechanical
coupling time was calculated from lateral mitral annulus (PA lateral), septal mitral
annulus (PA septum) and right ventricular tricuspid annulus (PA tricuspid) by TDI. Left
atrial volumes (maximum, minimum, and pre-systolic) were measured in the apical
four-chamber view with the disk method and were indexed to body surface area. Left
atrial mechanical functions (LAPEV, LAPEF, LAAEV, LAAEF, CV, LATEV) were
evaluated. P wave dispersion was obtained by 12-lead electrocardiography and was
calculated as subtracting the minimum Pwave duration frommaximumPwave duration
period. The results of prediabetic and control groups were analysed.
Results: Inter-atrial (PA lateral-PA tricuspid) and left atrial electromechanical delays
were found to be signiﬁcantly longer in patients with prediabetes than the control group
(21.510.5 vs 13.85.6 msec; p < 0.001, 12.58.1 vs 6.73.7, p < 0.001, respec-
tively). Maximum and pre-systolic volumes were found to be similar in both groups
(29.17.2 to 27.18.2, p¼0.24, 18.64.4 to 17.86.6, p¼0.14, respectively). In the
prediabetic patients, LATEV, LAAEV, CV and LAAEF were found to be higher than
the control group (18,86,3 vs 16,14,5, p¼0,01; 8,73,1 to 5,72,4; p<0,001,
31,38,3 vs 27,59,7, p¼0,047; 0,530,16 vs 0,310,13, p<0,001, respectively).
In prediabetic patients, P-wave dispersion was found to be longer than the control
group (55,311,1 msec to 28.95.9 msec, p<0.001, respectively).
Conclusıon: Prolonged atrial electromechanical delay and prolonged PWD suggested
that prediabetic population have an increased risk for development of AF than the
normal population. Impaired left atrial mechanical functions could be a predictor of
the heart failure and atrial ﬁbrillation which may develop in future. In our opinion, in
patients with presiabetes, some precautions are to be taken before the development of
overt diabetes, may prevent such cardiovascular complications as AF and heart failure.
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Occurrence and progression of coronary artery disease (CAD) and heart failure
(HF) are accompanied by worsening of autonomic regulation of circulation. In its turn,
this contributes to development of supraventricular arrhythmias. In this connection,
neural activity modulation may be an effective approach to treatment and prevention.
Methods: Estimation of sympathetic and parasympathetic activity in 40 patients with
CAD and paroxysmal atrial ﬁbrillation (AF) and in 40 healthy subjects was performed
by Valsalva maneuver test, evaluation of heart rate variability (HRV) and bloodERS C143
